75%Confidence
0Views
FDASource
2026-03-17Date
Summary
Defective blister packaging for Midodrine tablets creates patient safety concerns and potential liability for The Harvard Drug Group, possibly leading to increased regulatory oversight of their packaging operations. This packaging failure could disrupt supply of this blood pressure medication and trigger competitor gains.
Actionable: Verify packaging integrity for products from Major Pharmaceuticals and consider temporary alternative suppliers for Midodrine.
AI Confidence: 75%
Data Points
firmThe Harvard Drug Group LLC
classificationClass II
statusOngoing
distributionNationwide US.
productMidodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapol
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now